Granulocyte colony-stimulating factor (G-CSF) is a hematopoietic growth factor produced by mesenchymal and myeloid cells following activation by inflammatory stimuli. It has previously been shown that a region of the G-CSF promoter, (-200 to -165) containing the decanucleotide CK-1 element and two repeated sequences that resemble nuclear factor (NF)-interleukin-6 (IL-6) binding sites, is required for activation of the G-CSF gene by tumor necrosis factor-cu (TNF-a) and IL-lP. We now show that the NF-KB p65 protein can bind to and activate this TNF response region. There are several unusual features of this p65 interaction with the TNF response region. First, NF-KB p65 but not the related HE EXPRESSION OF cytokine genes involved in immune and inflammatory responses is generally inducible in specific cell types. The rel or nuclear factor (NF)-KB family of transcription factors has been implicated in the inducible expression of many immune and inflammatory cytokines including interleukin-2 (IL-2),'.' L-8; IL-6: granulocyte-macrophage colony stimulating factor (GM-CSF):
KB complex is composed of a heterodimer of two proteins, p50 and p65.' Other family members may also heterodimerize to generate functionally distinct transcription factors. ' Each dimeric complex appears to have related but distinct sequence requirements for DNA binding and function.' Following cell activation, NF-KB proteins are released from a complex with IKB in the cytoplasm and translocated to the nucleus as a functional transcription factor.' Prolonged activation also involves increased expression from at least some of the genes that encode NF-KB proteins."
Members of the CCAAT/enhancer binding protein (C/ EBP) family of transcription factors have also been implicated in regulating the expression of inflammatory cytokines as well as acute phase response genes. Some CEBP proteins are expressed constitutively and their levels are altered on cell differentiation,""' whereas others, such as CEBPP and CEBPy, are inducible in response to inflammatory mediat o r~. " * '~ The best characterized inducible CEBP protein is NF-IL6 (CEBPP, IL-6DBP, NF-IL6 was first isolated and cloned as a transcription factor required for L 1 induction of the IL-6 gene." It was subsequently shown to respond to IL-6 and activate the expression of some acute phase genes in the 1 i~e r . l~ Granulocyte-colony stimulating factor (G-CSF) is an important hematopoietic cytokine that is induced in mesenchymal and myeloid cells in response to inflammatory mediators. I6 We have previously identified two essential regions in the human G-CSF promoter required for TNF-a and ILlp response in human embryonic lung (HEL) fib rob last^.'^ One of these regions contains an octamer elementI7 and the second region contains the CK-1 element (consensus 5'GRGRTTNCYY3'), a decanucleotide found in many hematopoietic growth factor genes.I8 A recent polymerase chain reaction (PCR)-based screen for optimal p50 and p65 binding sites showed that each homodimeric protein has a distinct sequence preference? A 7 out of 10 match to the p65 consensus can be found across the CK-1 element of G-CSF (consensus S'GGGRNTTTCC3'; G-CSF S'CAGAGAlTCC3'). It has recently become apparent that this TNF response region also contains two directly repeated NF-IL6 consensus elements (5'A'ITNNGNAAT3').'7.'9 The first 5' NF-IL6 consensus element overlaps the CK-1 element and the second 3' element occurs immediately downstream (see Fig  1) . The equivalent regions of the mouse G-CSF promoter are required for lipopolysaccharide &PS) induction in mouse macrophages." A promoter fragment, termed the TNF response region, that contains the CK-1 decanucleotide element and the two NF-IL6 consensus elements, independently confers TNFa/lL-lP inducibility on a heterologous promoter, a function that is abolished by single point mutations in the CK-l element." We now show that overexpression of NF-KB p65 protein also activates the G-CSF TNF response region and that this transactivation requires both the CK-1 element and the NF-IL6 consensus elements. Furthermore we show that the TNF response region binds both p65 and NF-IL6 either independently or cooperatively as a complex of both proteins. 
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MATERIALS AND METHODS
Plasmid consrructs. All oligonucleotides were synthesized on an Applied Biosystems model 381A DNA synthesizer (Applied Biosystems, Los Angeles, CA) and full-length material purified using polyacrylamide gel electrophoresis. The oligonucleotides were then phosphorylated and annealed to yield double stranded DNA." The sequences of the oligonucleotides are described in Fig 1. The fragments were cloned into Bluescript SK(-) using EcoRI ends. Inserts from clones containing an appropriate number and orientation of inserts were excised with BamHl/HindIII and subcloned into pBLCAT2, which contains the basal thymidine kinase promoter." pCK-1(4+) containing the G-CSF TNF response region, pCK-11 2(5+) containing the GM-CSF CK-1 element and surrounding sequences and pIg~(5), all cloned upstream of the tk promoter in pBL CAT2, have been previously described"~" (Fig 1) . Sequences of the oligonucleotides used to generate these reporters are shown in Fig  1. pCK-IM5(3) has three copies of oligonucleotides with a 3-bp mutation in the CK-1 element (Fig l) , pCK-lM6(5) contains five copies with a 3-bp mutation in the second NF-IL6 consensus element, pGWG(3) and pG/GM(3) have three copies of hybrid GM-CSF and G-CSF CK-l regions (Fig 1) .
Full-length cDNAs for murine NF-KB ~5 0~~
and ~6 5~~ were excised from Bluescript clones using Nor I and cloned into a Not I linearized Rc/CMV expression vector (Invitrogen Corp, San Diego, CA) to generate CMVp65(+) and CMVp50(+). An Apa I fragment of the p50 cDNA encoding the first 464 amino terminal amino acids was also cloned into RclCMV (CMVp5OA). A CMV-based expression plasmid containing a hybrid cDNA for the rel homology domain of p50 (amino acid 1-370) and the transactivation region of p65 (amino acids 309-550) was a gift from C. Kunsch (Roche Institute of Molecular Biology, Nutley, NJ).
Cells and transfection. Human embryonic lung fibroblasts (Commonwealth Serum Laboratories, Melbourne, Australia) were maintained and transfected with diethyl aminoethyl dextran as previously described.'' For cotransfection experiments 5 pg of reporter plasmid and 10 pg of expression plasmid were used. The Jurkat T lymphoblastoid cell line was also maintained and transfected by electroporation as previously described." For cotransfections in Jurkat cells, 1 pg of reporter and 5 pg of expression plasmid was used. HEL fibroblasts were treated with TNF-a and IL-1B, cell extracts prepared and chloramphenicol acetyl transferase (CAT) assays performed as previously described." Percentage CAT conversion was determined using phosphorimage analysis (Molecular Dynamics, Inc. Sunnyvale, CA). Relative CAT activity was determined within each experiment using a value of one for the unstimulated pCK-1(4+) transfection.
Production of recombinant proteins. An Fsp VXho I fragment of p50 cDNAZ3 encoding 498 amino acids was subcloned into Bluescript KS(+), plasmid DNA was linearized with HindIII, to generate a truncated protein of 363 amino acids, and capped RNA transcripts generated using T7 RNA polymerase (Promega). Full length NF-IL6 cDNA from a CMV NF-IL6 cloneI3 (gift from S . Akira) was subcloned into pSP72, linearized with EcoRI and transcribed with SP6 polymerase. RNA was translated using wheat germ extract (Promega, Madison, WI) that was precleared for endogenous DNA binding proteins with GM-CSF CK-1 oligonucleotides coupled to sepharose beads. A fragment of p65 cDNA" encoding amino acids 1-3 13 was generated by PCR and subcloned in frame with the glutathione S-transferase protein into pGex-2T. The GST-p65 fusion protein was produced, purified, and cleaved with thrombin as described." DNA binding assays. Protein-to-DNA binding assays for p50 contained 2 pL in vitro translated protein, 2 pg polydI:dC, 3 mmoU L GTP, 0.2 ng radiolabeled double stranded oligonucleotide (5 to 10,000 cpm), TM buffer containing 50 mmol/L KC1" in a final volume of 20 pL. The reactions were analyzed on 5% polyacrylamide gels containing 50 mmol/L Tris pH 8. 
RESULTS
The NF-KB p65 protein transactivates the TNF response region of the G-CSF promoter. A reporter plasmid containing four copies of a 40-bp sequence spanning the CK-l element and the repeated NF-IL6 consensus elements of the G-CSF promoter, pCK-I(4+), was previously shown to be TNF-a and IL-10 responsive in human embryonic lung fibroblasts.lX Because we observed that the CK-1 element matches the p65 homodimer consensus binding site, we examined whether overexpression of NF-KB proteins could also activate the TNF response region of G-CSF. Overex- pression of NF-KB p65 transactivated pCK-1(4+) in HEL fibroblasts (average 17-fold) (Fig 2A) . Overexpression of NF-KB p50, either full-length (Fig 2A) or truncated forms (data not shown), did not activate pCK-1(4+). Cotransfection of p65 with p50 gave the same results as p65 alone (data not shown). A well-characterized NF-KB site from the immunoglobulin (1g)K gene [pIgrc(S)] was also transactivated (average sixfold) by p65 but not p50 overexpression in HEL fibroblasts (Fig 2A) . TNF-a treatment of HEL fibroblasts also induced expression from transfected pCK-1(4+) and pIg~(5) (Fig 2A) as previously described." Because p50 has previously been shown to lack transactivation ability following transfection, we used a p50165 hybrid protein construct, which is dependent on the p50 re1 homology domain for DNA binding but uses the transactivation domain of p65. 
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The hybrid p50/65 construct transactivated pIg~(5) (18.4-fold, average of four experiments) but not pCK-1(4+) in HEL fibroblasts (Fig 2B) . In this set of experiments, pCK-1(4+) was not as well activated by p65 compared with Fig  2A ( sevenfold compared with 17-fold) but nevertheless no activation by the p50/65 hybrid protein was detected. The p50/65 hybrid protein activated the IgK sequence better than did p65 alone indicating its function in these cells. The cell specificity of p65 transactivation of the G-CSF TNF response region was tested in Jurkat T cells where G-CSF is not normally expressed. pCK-1(4+) was only weakly responsive (fourfold) in Jurkat T cells whereas pIg~(5) was strongly activated by p65 (85-fold) (Fig 2C) . Overexpression of p50 gave low-level activation of pIg~(5) (fivefold) but not pCK-1(4+) (Fig 2C) .
NF-KB p65 transactivation and TNF-a induction of the CK-I region have similar sequence requirements. We have previously shown, either in the context of the intact G-CSF promoter17 or the pCK-1(4+) construct,'* that both the CK-1 decanucleotide element and the second NF-IL6 consensus element are required for TNF-a/IL-lP activation. We have also shown that the CK-1 element in the context of the GM-CSF promoter is not responsive to TNF-(Y/IL-~P.*~ To determine whether p65 transactivation and TNF-a activation have the same sequence requirements, we compared the response of a series of constructs containing intact or mutant G-CSF or GM-CSF sequences with p65 overexpression or TNF-a treatment. Mutations either in the CK-1 element (M5) or in the second NF-L6 consensus element (M6) abolished both the response to p65 and TNF-a (Fig 3) . The GM-CSF CK-1 construct (pCK-1/2(5+) also did not respond to either p65 or TNF-a (Fig 3) .
The GM-CSF CK-1 region contains one potential NF-L6 site overlapping the CK-1 element (see Fig 1) consensus elements, we generated a hybrid construct [pGM/ G(3)] containing the 5' end of the GM-CSF sequence linked to the 3' end of the G-CSF sequence whereby the CK-l element and its 5' flanking sequence were contributed by GM-CSF and the second NF-IL6 consensus element by G-CSF (Fig 1) . The reciprocal plasmid pG/GM(3) was also constructed (Fig 1) . p65 overexpression transactivated pGM/ G(3) but not pGjGM(3) (Fig 3) implying that the CK-1 element was functional only when linked to an additional NF-IL6 element. TNF-a also activated pGMlG(3) but not pG/GM(3) (Fig 3) . These data show that sequences other than the CK-1 p65 consensus binding site are required for p65 transactivation of the TNF response region and that p65 transactivation parallels the TNF-(w response.
The NF-KB p65 protein and NF-IL.6 both bind to the G-CSF TNF response region. The ability of p65 and p50 NF-KB proteins and NF-IL6 to bind DNA fragments spanning the G-CSF and GM-CSF CK-1 elements was tested. The p50 protein did not bind to either the G-or GM-CSF elements but did generate a complex with the IgK NF-KB element ( Fig  4A) . p50 also bound to an extended GM-CSF oligonucleotide that contained a previously described NF-KB site' downstream of CK-1 (Fig 4A) . The specific p50 complex was identified by inclusion of an anti-p50 antibody in the binding reactions. This antibody but not an anti-p65 antibody abolished the complex marked as p50 (Fig 4B) . The specificity of this complex was also determined by competition experiments (data not shown). All the other bands seen in the gel shift lanes are the binding of endogenous nonspecific proteins from the wheat germ extracts. The lack of p50 binding to the G-CSF sequence correlates with the failure of the p50/65 hybrid protein to transactivate these sequences. In contrast, NF-KB p65 binding was detected to both the Gand GM-CSF DNA fragments as well as to the IgK NF-KB site (Fig 4C) . Two complexes were detected with both the G-and GM-CSF probes. The upper complex could be com- peted with the IgK NF-KB oligonucleotide but not with a mutant from of this element (Fig 4C) indicating that this is authentic p65. The lower complex was nonspecific. p65 binding was reproducibly stronger to the GM-CSF compared with the G-CSF probe. Binding of p65 to either the G-CSF or GM-CSF probes was reduced by addition of an anti-p65 antibody but not with an anti-p50 antibody (Fig 4D) .
NF-IM also formed a complex with the G-CSF probe that migrated at the same position as the NF-IM complex formed with a probe of the same size containing an NF-IL6 binding site from the IL-6 gene13 (Fig 5) . The NF-IM complex formed on the IL-6 gene element was eliminated by mutation of the NF-IM consensus site (data not shown). The affinity of NF-IL6 binding to G-CSF was considerably lower than for the IL-6 gene element. Addition of an antibody against mouse CIEBP-p (equivalent of human NF-IM) abolished both the G-CSF and IL-6 element complexes (Fig 5) . An antibody against the unrelated NF-KB p50 had no effect on complex formation (Fig 5) . The specificity of the complex was further determined by competition with the wild type and mutant IL-6 oligonucleotides (see Fig 1) . The native but not the mutant IL-6 sequence competed for NF-IM binding to the G-CSF probe (Fig 5) .
NF-KB p65 and NF-ILb form a multiprotein complex with the G-CSF TNF response region. To determine if p65 and NF-IM could bind simultaneously to the TNF response region of the G-CSF promoter, p65 and NF-IM were mixed and DNA bound complexes analyzed. A new complex was DUNN ET AL detected, (marked x), migrating above the NF-IM band ( Fig  6A) . Binding reactions, in which one of the protein components was titrated with a fixed amount of the second component, were carried out to determine if cooperative binding was occurring. At a fixed concentration of p65, increasing amounts of NF-IM leads to an increase in complex x and a decrease in the p65 complex (Fig 6B) . Phosphorimager quantitation of these experiments showed that complex x formed at least three times as efficiently as the NF-IM complex alone. Therefore, it appears that the formation of the complex x is favored over the binding of individual proteins.
Antibodies to p65 and NF-IM were used to determine the components of complex x . An antibody to p65 abolished p65 binding to the CK-l region (see Fig 4D) but did not affect NF-IM binding (Fig 6C) . However, in p65/NF-IL-6 mixing experiments this antibody abolished not only the p65 complex but also the x complex (Fig 6C) . A complex that migrates slightly below the x complex was detected in some p65/NF-IL6 mixing experiments (see Fig 6C and D) . This complex (referred to as x' in Fig 6C) always migrated faster than the NF-IL6 alone complex and was always abolished by the anti-p65 antibody (Fig 6C) . The nature of this complex is unclear. An antibody to p50 had no effect on any of the complexes (Fig 6C) . In mixing experiments the CIEBP-0 antibody eliminated both the x and faster migrating complexes but did not affect p65 binding (Fig 6B) . The CIEBP-(Y antibody reduced the intensity of these complexes ( Fig  6C) . The CEBP-CY antibody was raised against the entire protein and, therefore, cross-reactivity with the related NF-IL6 protein is not surprising. Because complex x is abolished by antibodies to both NF-IL6 and p65 it implies that the complex represents simultaneous binding of both proteins to a single DNA fragment. Competition experiments using competitor oligonucleotides that bound only one or other of the proteins also indicated that complex x contained both p65 and NF-IL6 (Fig 6D) .
The ability of mutant sequences across the TNF response region were tested for their ability to bind NF-IM, p65 and the NF-IL6/p65 complex. Three mutants were chosen for this analysis; M8 has a mutation at the 5' end of the CK-l element, which we have shown to abolish p65 binding in the GM-CSF context" and p65 transactivation of the GM/ G hybrid (unpublished data). M5 and M6 have been shown here to abolish TNF and p65 response of the G-CSF sequence. M8 maintains NF-IM binding but has lost the capacity to bind p65 and form the p65/NF-IL6 complex (Fig 7A) . Conversely, M6 binds p65 but does not bind NF-IL6 nor the p65/NF-IL6 complex (Fig 7A) . M5 binds neither p65 nor NF-IL6 (Fig 7A) . These data show that the binding sites for both proteins must be intact to generate the p65/NF-IL6 complex and function. Because the G-CSF TNF response region and the GM/G hybrid but not the GM-CSF CK-l region were transactivated by p65 (see Fig 3) . we tested the ability of these sequences to bind p65 and NF-IM individually and to form complex x. Both G and GWG sequences could bind NF-IL6 weakly but the GM sequence did not (Fig 7B) . The faint band migrating in the region of NF-IM with the GM-CSF probe is nonspecific and found in wheat but did abolish complex x (lane 6). Antibodies to C/EBP ( I and p both reduced complex x formation but not p65 binding (lanes 14 and 15) .
The anti-p50 antibody had no effect on the complex (lane 7). (D) Binding sites for both NF-IL6 and NF-KB proteins can compete for complex xformation. Increasing concentrations (shown in nanograms; fivefold to 100-fold excess) of the IL-6 (lanes 2-51 and lgrc (lanes 6-91 oligonucleotides were added to binding reactions with the G radiolabeled probe, NF-IL6 and p65 proteins. Lane l had no competitor added. germ extracts without NF-IL6 mRNA (data not shown). All three DNA fragments bind p65 with strongest binding observed to the GM-CSF sequence ( Fig 7B" compare with Fig 4C) . More importantly, complex x was seen when p65 and NF-IL6 were mixed and tested for binding to the hybrid GMIG sequence but was not observed with the GM sequence (Fig 7B) . Neither the p65 complex nor complex x were detected with the NF-IL6 site from the IL-6 gene (Fig 7B) . These results show that the putative p65/NF-IL6 complex x is only detected with oligonucleotides that bind both NF-IL6 and p65 independently. The ability to form this complex also correlates with the ability of these sequence elements to be activated by TNF-a/IL-10 and to respond to p65 overexpression.
DISCUSSION
We have shown here that NF-KB p65 binds to and transactivates the TNF response region of the G-CSF promoter. The unique feature of this transactivation is that it appears to be dependent on the simultaneous binding of NF-KB p65 and NF-IL6 or related CEBP proteins to this region. The observation that NF-KB p65 bound to the G-CSF TNF response region but that NF-KB p50 did not is in contrast to most NF-KB sites, which can generally bind p50 more avidly than ~6 5 . '~ A 7 and 8 out of 10 match to the recently defined p65 consensus9 can be found across the CK-1 element of G-CSF and GM-CSF, respectively (Fig 8A) , whereas the match to the p50 consensus is only 4 and 5 out of 10. The potential p65 binding site lies across the 5' end of the CK-I element ( Fig 8A) and mutations across this region in G-CSF ( Fig  6D) in GM-CSF*' have confirmed that this region is required for p65 binding. We have previously shown that NF-KB purified from bovine spleen did not bind to the G-CSF TNF response region nor the GM-CSF CK-I element.'* This purified material was enriched for NF-KB p50 and so p65 binding may not have been detectable. Binding of p50/p65 heterodimers or NF-KB from crude nuclear extracts was also not detected to the G-CSF TNF response region (unpublished observations). The CK-I element also binds another TNF-a inducible protein, NF-GMa." Antibodies against NF-KB or CEBP proteins do not affect NF-GMa binding (unpublished observation). Whether NF-GMa can bind together with p65 or NF-IL6 and its role in activation of this region is still unclear.
NF-IL6 binding to the TNF response region was also detected. Recently, Nishizawa et aIz9 cloned another CEBP protein using this G-CSF promoter fragment as a probe. We have not mapped the exact binding site for NF-IL6 but the noncoding strands of the direct repeats both match the NF-IL6 consensus sequence" (Fig 8B) . It is clear that both repeated elements are required for function because all the mutations shown here to abolish function lie within these repeats (see Fig 1) . The M5 but not the M6 mutation abolishes p65 binding (Fig 7A) . The lack of M6 function cannot be accounted for by lack of p65 binding and may be associated with the abolition of an NF-IL6 binding site. Methylation interference experiments will be required to determine the precise binding sites for NF-IL6 and also p65.
Although p65 can bind to a number of DNA fragments containing CK-1 elements, transactivation only occurs when the DNA fragment can also bind NF-IL6. This is in contrast with most of the previously described NF-KB sites, which function independentl~.~' Other genes have been shown to have functionally linked NF-IL6 and NF-KB sites. In the IL-6 gene promoter NF-KB and NF-IL6 sites, which are 70 bp apart, are required for activity but can function independ e n t l~.~. '~ The PCR-based screen for p65 binding sites, discussed above, detected the NF-KB sites in both the angiotensinogen and the IL-8 gene promoters.' This is intriguing because these promoters both have overlapping or adjacent NF-KB and NF-IL6 sites located in functional promoter rep65 but not p50 homodimers also did not bind p50/p65 heterodimers and it was proposed by Kunsch et al' that p65 homodimers and not p50/p65 mediated the activity of the p65-specific binding sites. We have shown that a p50165 hybrid protein, the DNA binding of which is mediated by p50, does not transactivate the G-CSF TNF response region but does transactivate the IgK NF-KB site. The result supports the lack of p50 binding in vitro by showing that a protein dependent on p50 sequences for DNA binding cannot transactivate this region in vivo. It is possible that p65 homodimers activate the G-CSF TNF response region but that efficient activation requires the simultaneous binding of NF-IL6 or related CEBP proteins.
There appears to be cooperative binding of p65 and NF-IL6 to the TNF response region of G-CSF. The formation of this ternary complex correlates with the function of this region. Mutations that abolish complex formation but allow binding of one or other of the proteins are not active. Furthermore, the G-CSF and GM/G sequences that can form the ternary complex are p65 or TNF-a responsive, whereas the GM-CSF sequence that binds p65 but not the ternary complex is not activated by either p65 or TNF-a. We have not It is likely that NF-KB p65 is required for TNF-a/IL-10 activation of the G-CSF promoter because TNF-a activation has sequence requirements identical to those of p65 transactivation. In addition, the expression of antisense NF-KB RNAs can block the TNF-a-mediated activation of the CK-1 region (unpublished observations). TNF-a activation has also been shown to upregulate NF-IL6 f~ncti0n.l~ It is likely that the expression and function of both NF-KB p65 and NF-IL6 is required for TNF-aDL-lp activation of the G-CSF promoter. It is clear from our data that only those sequences that bind both NF-KB p65 and NF-IL6 are functional. How-ever, transfection experiments with both NF-KB p65 and NF-IL6 have not shown increased levels of expression over those with NF-KB p65 alone. There are at least two possible explanations for this observation. First, it has been shown that overexpressed NF-IL6 requires posttranslational modification for f~ncti0n.l~ However, TNF-a treatment of cells that have been transfected with Rc/CMV NF-IL6, also failed to give increased levels of transactivation (unpublished observations). Second, it is possible that the HEL fibroblasts used in these experiments already contain sufficient quantities of CEBP proteins that can cooperate with the overexpressed NF-KB p65 to mediate activation.
Expression of genes such as G-CSF and IL-8 involved in inflammatory responses may be dependent on interaction between NF-KB and NF-IL6, generating a subset of genes with a narrower range of response than those genes activated by NF-KB or NF-IL6 alone. This is borne out by our experiments in Jurkat 
